By Ned Pagliarulo – PharmaVoice –
A commission urged the U.S. government to prioritize biotechnology funding and policies to stay ahead of China in fields it argued are vital to national security.
The U.S. risks losing a once-decisive edge over China in biotechnology unless the federal government prioritizes the sector’s advancement with new funding and policies, a bipartisan commission warned in a report issued Tuesday.
At minimum, the commission wrote, the U.S. should invest at least $15 billion over the next five years to strengthen the country’s biotech capabilities. It also called for a more “proactive” government strategy, including the establishment of a new National Biotechnology Coordination Office within the White House.
